Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)
在中国，PCSK-9 抑制剂联合他汀类药物与他汀类药物单药治疗在动脉粥样硬化性心血管疾病高危患者中的真实世界疗效（RWE-PCSK 研究）
期刊:Journal of Geriatric Cardiology
影响因子:2.6
doi:10.11909/j.issn.1671-5411.2021.04.005
Liu, Yu-Qi; Li, Dan-Dan; Chai, Meng; Cong, Hong-Liang; Cong, Xiao-Qiang; Dai, Jun; DU, Rong-Pin; Gao, Ming; Guo, Jin-Cheng; Guo, Yan-Qing; Hong, Xiao-Jian; Huang, Rong-Chong; Jia, Feng-Shun; Li, Jia-Yu; Li, Qing; Liu, Jia-Mei; Liu, Xin-Ping; Liu, Yu-Guo; Nie, Hong-Gang; Shao, Bing; Shen, Xiao-Yu; Song, Hai-Qing; Song, Yi-Jun; Wang, Li-Jun; Wang, Shuo; Wu, Dong-Mei; Xia, Jing; Yang, Zhi-Yong; Yu, Hong-Ying; Zhang, Hui; Zhang, Tie-Mei; Zhao, Ji-Yi; Zhao, Liang-Chen; Zheng, Ming-Qi; Chen, Yun-Dai
